InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.15
(
1.17%
)
US TECH 100
18,138.40
(
1.69%
)
Dow Jones
39,908.00
(
0.88%
)
Brent Oil
82.90
(
0.29%
)
Bitcoin
65,844.63
(
-0.63%
)
Post# of 146215
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

KMBJN

Send PM Follow Ignore
Followers 52
Posts 2230
Boards Moderated 0
Alias Born 07/06/2011

KMBJN

Re: loanranger post# 146044

Thursday, 04/06/2023 5:38:23 PM

Thursday, April 06, 2023 5:38:23 PM

Post# of 146215
Oh, what a tangled web Diwan weaves.

https://www.sec.gov/Archives/edgar/data/1379006/000110465923040296/tm2311179d1_ex10-1.htm

Says that Karveer develops the drug at cost +30%. Then NNVC gets 70% of sales in India, and Karveer just 30%. Assume Karveer would manufacture and promote, so this would seem to be a decent deal for NNVC. I'm sure the details are more complicated. Like where does Theracour license fit in ... which I recall being 30% of sales also? Thus leaving just 40% royalties from India sales ... after NNVC pays for trials?

But who knows. All we need to know is that Diwan takes care of Diwan first.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NNVC News
More NNVC News
InvestorsHub NewsWire

FEATURED Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • May 15, 2024 10:30 AM

Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM

Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • BLEG • May 15, 2024 8:30 AM

Alliance Creative Group (ACGX) Releases Q1 2024 Financial and Disclosure Report with an 88% increase in Net Income from Q1 2023 to Q1 2024 • ACGX • May 15, 2024 8:30 AM

Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotechnology Sector • CATV • May 15, 2024 8:00 AM

POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • POET • May 14, 2024 10:09 AM

Start posting your company's news
Only $200 per official company press release!